EQUITY TRANSACTIONS

3 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS

During the three months ended September 30, 2021 and 2020, respectively, stock options to purchase shares of the Company's common stock were exercised as follows:

	Three-Months Ended September 30,
	2021		2020
Options exercised	—		50,531
Proceeds (in thousands)	$	—	$	225
Average exercise price per share	$	—	$	4.44

As of September 30, 2021, there was $1.5 million of stock compensation expense related to non-vested awards, which is expected to be recognized over a weighted average period of 2.98 years.

On August 30, 2021, the Company closed its previously announced underwritten secondary offering of a total of 2,070,000 shares of its common stock at a public offering price of $8.65 per share, including the exercise in full by the underwriter of its option to purchase an additional 270,000 shares to cover over-allotments in connection with the offering. After the underwriting discount and offering expenses payable by the Company of $1.1 million, the Company received net proceeds of approximately $16.8 million.